CompuGroup Medical (UK) Today
| 0MSD Stock | 14.03 0.01 0.07% |
Performance0 of 100
| Odds Of DistressLess than 9
|
CompuGroup Medical is selling for under 14.03 as of the 22nd of November 2024; that is 0.07% up since the beginning of the trading day. The stock's lowest day price was 14.03. CompuGroup Medical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for CompuGroup Medical AG are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Commercial & Professional Services | Classification Industrials |
CompuGroup Medical is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 49.56 M outstanding shares. More on CompuGroup Medical AG
Moving together with CompuGroup Stock
| 0.65 | 0IC8 | Dollar Tree Earnings Call This Week | PairCorr |
Moving against CompuGroup Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
CompuGroup Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. CompuGroup Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding CompuGroup Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO MD | Daniel Gotthardt | ||||
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Environmental & Facilities Services, Commercial & Professional Services, Industrials, Drugs, Industrials, Commercial Services & Supplies, Software & IT Services, Technology (View all Sectors) | ||||
CompuGroup Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to CompuGroup Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCompuGroup Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CompuGroup Medical's financial leverage. It provides some insight into what part of CompuGroup Medical's total assets is financed by creditors.
| |||||
CompuGroup Medical AG (0MSD) is traded on London Exchange in UK and employs 8,412 people. CompuGroup Medical is listed under Environmental & Facilities Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CompuGroup Medical's market, we take the total number of its shares issued and multiply it by CompuGroup Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CompuGroup Medical operates under Commercial Services & Supplies sector and is part of Industrials industry. The entity has 49.56 M outstanding shares.
CompuGroup Medical generates positive cash flow from operations, but has no cash available
Check CompuGroup Medical Probability Of Bankruptcy
Ownership AllocationCompuGroup Medical holds a total of 49.56 Million outstanding shares. CompuGroup Medical AG retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CompuGroup Ownership Details
CompuGroup Medical Risk Profiles
Although CompuGroup Medical's alpha and beta are two of the key measurements used to evaluate CompuGroup Medical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.59 | |||
| Standard Deviation | 2.07 | |||
| Variance | 4.28 | |||
| Risk Adjusted Performance | (0.05) |
CompuGroup Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in CompuGroup Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
CompuGroup Medical Corporate Management
Elected by the shareholders, the CompuGroup Medical's board of directors comprises two types of representatives: CompuGroup Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CompuGroup. The board's role is to monitor CompuGroup Medical's management team and ensure that shareholders' interests are well served. CompuGroup Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CompuGroup Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angela Teufer | Connectivity DACH | Profile | |
| Ulrich Thome | MD Board | Profile | |
| Daniela Hommel | Chief Officer | Profile | |
| Emanuele Mugnani | MD Board | Profile | |
| Helge Wei | Senior Connectivity | Profile | |
| Hannes Reichl | MD Board | Profile | |
| Alexander Weimer | Head Communications | Profile |
Additional Tools for CompuGroup Stock Analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.